Treatment of atopic eczema with oral alitretinoin
Conflicts of interest: M.G. and A.W. have received financial support and S.M., J.C.P. and T.R. have conducted clinical trials with alitretinoin and have received financial support from Basilea Pharmaceuticals GmbH, the manufacturer of oral alitretinoin. However, there was no financial support for the clinical observation submitted here.
No abstract is available for this article.